Here come drug prices in TV ads

According to a report in FiercePharmaMarketing, J&J’s Janssen unit might be the first US pharma company to include price information in its TV advertising for Xarelto, a widely used blood thinner. The ads, which include a $448 list price for […]

Read More

Artificial Intelligence: Beyond the glamor

After the flurry of hype, artificial intelligence is on the rise and enabling a smarter, more efficient and more effective business. Once-scrappy experiments have now matured into high-impact enterprise applications. Many organizations, however, are still unclear about how to build […]

Read More

A Conversation with Tommy Bramley, Lash Group

Lash Group, a business unit of AmerisourceBergen since 1998, was one of the pioneering firms established to provide patient-support services, sponsored by pharma companies, in the specialty-pharmaceutical arena. It currently manages over 100 drug programs, with over 1,000 associates, mostly […]

Read More

Improving medication adherence with technology

Non-adherence to therapy is widely recognized as an ever-present problem in healthcare generally and the pharma industry specifically, which forgoes some $250 billion annually in lost sales. The picture is changing, somewhat, from past years, as health systems now have […]

Read More

The outcomes-based reimbursement environment

As the US healthcare system continues to shift its reimbursement model from volume-based (fee for service) to value-based (fee for outcome), the landscape for specialty care is becoming increasingly complex. At the same time, a growing number of innovative specialty […]

Read More